Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Kidney International

Volumn 90, Issue 6, 2016, Pages 1164-1174

  Jha, Vivekanand ^a,b   Arici, Mustafa ^c   Collins, Allan J ^d,e   Garcia Garcia, Guillermo ^f   Hemmelgarn, Brenda R ^g   Jafar, Tazeen H ^h,i,j   Pecoits Filho, Roberto ^k   Sola, Laura ^l   Swanepoel, Charles R ^m   Tchokhonelidze, Irma ⁿ   Wang, Angela Yee Moon ^o   Kasiske, Bertram L ^p   Wheeler, David C ^q   Spasovski, Goce ^r   Agodoa, Lawrence ^p   Ahmad, Ghazali ^s   Anantharaman, Vathsala ^h   Arogundade, Fatiu ^s   Ashuntantang, Gloria ^s   Ballal, Sudarshan ^a   Bamgboye, Ebun ^s   Banchuin, Chatri ^s   Bogov, Boris ^s   Bunnag, Sakarn ^s   Chailimpamontri, Worawon ^s   Chawanasuntorapoj, Ratana ^s   Claure Del Granado, Rolando ^s   Eiam Ong, Somchai ^s   Gomez, Lynn ^s   Gómez, Rafael ^s   Goumenos, Dimitrios ^s   Phan, Hai An Ha ^s   Imonje, Valentine ^s   Ingsathit, Atiporn ^s   Jarraya, Faiçal ^s   Jiwakanon, Sirin ^s   Kantachuvesiri, Surasak ^s   Khanna, Umesh ^a   Kher, Vijay ^a   Kitositrangsikun, Kamol ^s   Liu, Zhi Hong ^s   Lorvinitnun, Pichet ^s   Nseka, Nazaire ^s   Obrador, Gregorio T ^f   Okpechi, Ikechi ^m   Onsuwan, Duangta ^s   Ophascharoensuk, Vuddhidej ^s   Osafo, Charlotte ^s   Peiris, David ^s   Pichaiwong, Warangkana ^s   Praditpornsilpa, Kearkiat ^s   Rajapurkar, Mohan ^a   Rychlik, Ivan ^s   Saadi, Gamal ^s   Polo, Vicente Sanchez ^s   Sangthawan, Pornpen ^s   Suwan, Nirut ^s   Tesar, Vladimir ^s   Thirakhupt, Prapaipim ^s   Trakarnvanich, Thananda ^s   Tsukamoto, Yusuke ^s   Tungsanga, Kriang ^s   Vanichakarn, Supat ^s   Vazelov, Evgueniy ^s   Wanner, Christoph ^s   Were, Anthony ^s   Zakharova, Elena ^s   more..

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HACETTEPE UNIVERSITY   (Turkey)

^d MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF GUADALAJARA   (Mexico)

^g UNIVERSITY OF CALGARY   (Canada)

^h DUKE NUS MEDICAL SCHOOL   (Singapore)

ⁱ AGA KHAN UNIVERSITY   (Pakistan)

^j AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^k PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^l Groote Schuur Hospital and University of Cape Town ^*  (Uruguay)

^m UNIVERSITY OF CAPE TOWN   (South Africa)

ⁿ TBILISI STATE MEDICAL UNIVERSITY   (Georgia)

^o UNIVERSITY OF HONG KONG   (Hong Kong)

^p HENNEPIN COUNTY MEDICAL CENTER   (United States)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^s NONE   (Russian Federation)

more..

Author keywords

acute kidney injury; advocacy; chronic kidney disease; clinical practice guidelines; implementation; low and middle income countries

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; CHRONIC KIDNEY DISEASE; END STAGE RENAL DISEASE; HEALTH CARE DELIVERY; HEALTH CARE MANPOWER; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; KIDNEY DISEASE; LOW INCOME COUNTRY; MEDICAL EDUCATION; MIDDLE INCOME COUNTRY; NEPHROLOGIST; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; COST OF ILLNESS; DEVELOPING COUNTRY; MANPOWER;

COST OF ILLNESS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH POLICY; HUMANS; KIDNEY DISEASES; PRACTICE GUIDELINES AS TOPIC;

EID: 84997327482     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.09.009     Document Type: Article

References (67)

1. 1 Liyanage, T., Ninomiya, T., Jha, V., et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385 (2015), 1975–1982.
2. 2 Mehta, R.L., Cerda, J., Burdmann, E.A., et al. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385 (2015), 2616–2643.
3. 3 Mehta, R.L., Burdmann, E.A., Cerda, J., et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet 387 (2016), 2017–2025.
4. 4 Stanifer, J.W., Muiru, A., Jafar, T.H., Patel, U.D., Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant 31 (2016), 868–874.
5. 5 Luyckx, V.A., Brenner, B.M., Birth weight, malnutrition and kidney-associated outcomes–a global concern. Nat Rev Nephrol 11 (2015), 135–149.
6. 6 Nugent, R.A., Fathima, S.F., Feigl, A.B., et al. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 118 (2011), c269–c277.
7. 7 Bawaskar, P.H., Bawaskar, H.S., Eliminating acute kidney injury by 2025: an achievable goal for India. Lancet, 386, 2015, 855.
8. 8 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
9. 9 Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
10. 10 Mills, K.T., Xu, Y., Zhang, W., et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88 (2015), 950–957.
11. 11 Tonelli, M., Agarwal, S., Cass, A., et al. How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. Kidney Int 85 (2014), 1269–1274.
12. 12 Jha, V., Garcia-Garcia, G., Iseki, K., et al. Chronic kidney disease: global dimension and perspectives. Lancet 382 (2013), 260–272.
13. 13 Francis, E.R., Allen, A.K., Herrera-Anazco, P., et al. Establishing a higher priority for chronic kidney disease in Peru. Lancet Glob Health 4 (2016), e17–e18.
14. 14 de Vries, E.F., Rabelink, T.J., van den Hout, W.B., Modelling the cost-effectiveness of delaying end-stage renal disease. Nephron 133 (2016), 89–97.
15. 15 Hossain, M.P., Goyder, E.C., Rigby, J.E., et al. CKD and poverty: a growing global challenge. Am J Kidney Dis 53 (2009), 166–174.
16. 16 Puska, P, Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland. Public Health Medicine 4 (2002), 5–7.
17. 17 Coca, S.G., Singanamala, S., Parikh, C.R., Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81 (2012), 442–448.
18. 18 Thakar, C.V., Christianson, A., Himmelfarb, J., et al. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol 6 (2011), 2567–2572.
19. 19 Olowu, W.A., Niang, A., Osafo, C., et al. Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review. Lancet Glob Health 4 (2016), e242–e250.
20. 20 Problemas públicos y agenda de gobierno. Villanueva Aguilar LF, ed. Miguel Angel Porrua Grupo Editorial, Mexico, DF, 1993.
21. 21 Patterson, S.C., Davidson, R.H., Ripley, R.B., (eds.) A More Perfect Union: Introduction to American Government, 1982, Dorsey Press, Homewood, IL.
22. 22 The George Institute for Global Health. Smart phone project in rural Andhra Pradesh (Pilot phase study). Available at: http://www.georgeinstitute.org/projects/smart-phone-project-in-rural-andhra-pradesh-pilot-phase-study. Accessed August 14, 2015.
23. 23 The Chronic Kidney Disease (CKD) Clinical Pathway. The chronic kidney disease (CKD) clinical pathway. Available at: http://www.CKDpathway.ca. Accessed August 14, 2015.
24. 24 ISN-COMGAN: the Latin American Intent. ISN News, 29, March 2009. Available at: http://www.theisn.org/images/ISN_News_Archive/ISN_News_29_March_2009.pdf. Accessed August 14, 2015.
25. 25 Mesoamerican nephropathy. Report from the first international research workshop on Mesoamerican Nephropathy. Available at: http://www.saltra.una.ac.cr/index.php?option=com_content&view=article&id=90&Itemid=260. Accessed on August 14, 2015.
26. 26 Pan American Health Organization. Regional Consultation: priorities for cardiovascular health in the Americas. Key messages for policy makers. Orduñez-Garcia P, Campillo-Artero C, eds. Washington, DC. PAHO, 2011.
27. 27 Manual de incidencias en Politicas Publicas. Tapia-Alvarez M, Campillo-Carrete B, Cruickshank-Soria S, Morales-Sotomayor G, eds. Alternativas y Capacidades AC; Mexico, DF. 2010. Available at: http://www.alternativasycapacidades.org.
28. 28 van der Veer, S.N., Tomson, C.R., Jager, K.J., et al. Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines. Nephrol Dial Transplant 29 (2014), 951–957.
29. 29 National Institute for Health and Clinical Excellence. How to change practice: understand, identify and overcome barriers to change. 2007. Available at: https://www.nice.org.uk/media/default/about/what-we-do/into-practice/support-for-service-improvement-and-audit/how-to-change-practice-barriers-to-change.pdf. Accessed 26 June 2016.
30. 30 Liu, F.X., Rutherford, P., Smoyer-Tomic, K., et al. A global overview of renal registries: a systematic review. BMC Nephrol, 16, 2015, 31.
31. 31 White, S.L., Chadban, S.J., Jan, S., et al. How can we achieve global equity in provision of renal replacement therapy?. Bull World Health Organ 86 (2008), 229–237.
32. 32 Obrador, G.T., Rubilar, X., Agazzi, E., et al. The challenge of providing renal replacement therapy in developing countries: The Latin American perspective. Am J Kidney Dis 67 (2016), 499–506.
33. 33 Thomas, B., Wulf, S., Bikbov, B., et al. Maintenance dialysis throughout the world in years 1990 and 2010. J Am Soc Nephrol 26 (2015), 2621–2633.
34. 34 Calice-Silva, V., Hussein, R., Yousif, D., et al. Associations between global population health indicators and dialysis variables in the Monitoring Dialysis Outcomes (MONDO) consortium. Blood Purif 39 (2015), 125–136.
35. 35 Liu, F.X., Gao, X., Inglese, G., et al. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit Dial Int 35 (2015), 406–420.
36. 36 Barsoum, R.S., Khalil, S.S., Arogundade, F.A., Fifty years of dialysis in Africa: challenges and progress. Am J Kidney Dis 65 (2015), 502–512.
37. 37 Rosa-Diez, G., Gonzalez-Bedat, M., Pecoits-Filho, R., et al. Renal replacement therapy in Latin American end-stage renal disease. Clin Kidney J 7 (2014), 431–436.
38. 38 Davison, S.N., Levin, A., Moss, A.H., et al. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int 88 (2015), 447–459.
39. 39 Etheredge, H., Paget, G., Ethics and rationing access to dialysis in resource-limited settings: the consequences of refusing a renal transplant in the South African state sector. Dev World Bioeth 15 (2015), 233–240.
40. 40 Tantivess, S., Werayingyong, P., Chuengsaman, P., et al. Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. BMJ, 346, 2013, f462.
41. 41 Blantz, R.C., Handing out grades for care in chronic kidney disease: nephrologists versus non-nephrologists. Clin J Am Soc Nephrol 2 (2007), 193–195.
42. 42 Minutolo, R., Lapi, F., Chiodini, P., et al. Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study. Clin J Am Soc Nephrol 9 (2014), 1586–1593.
43. 43 Naicker, S., Eastwood, J.B., Plange-Rhule, J., et al. Shortage of healthcare workers in sub-Saharan Africa: a nephrological perspective. Clin Nephrol 74 Suppl 1 (2010), S129–S133.
44. 44 Tollman, S.M., Kahn, K., Sartorius, B., et al. Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet 372 (2008), 893–901.
45. 45 Bhutta, Z.A., Salam, R.A., Das, J.K., et al. Tackling the existing burden of infectious diseases in the developing world: existing gaps and the way forward. Infect Dis Poverty, 3, 2014, 28.
46. 46 Jafar, T.H., Hatcher, J., Poulter, N., et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med 151 (2009), 593–601.
47. 47 Muula, A.S., Is there any solution to the “brain drain” of health professionals and knowledge from Africa?. Croat Med J 46 (2005), 21–29.
48. 48 Peiris, D., Praveen, D., Johnson, C., et al. Use of mHealth systems and tools for non-communicable diseases in low- and middle-income countries: a systematic review. J Cardiovasc Transl Res 7 (2014), 677–691.
49. 49 Bolton, W.K., The role of the nephrologist in ESRD/Pre-ESRD care: a collaborative approach. J Am Soc Nephrol 9 (1998), S90–S95.
50. 50 Cortes-Sanabria, L., Cabrera-Pivaral, C.E., Cueto-Manzano, A.M., et al. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial. Am J Kidney Dis 51 (2008), 777–788.
51. 51 Jafar, T.H., Allen, J.C., Jehan, I., et al. Health education and general practitioner training in hypertension management: long-term effects on kidney function. Clin J Am Soc Nephrol 11 (2016), 1044–1053.
52. 52 Benghanem Gharbi, M., Elseviers, M., Zamd, M., et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid “over”- and “under”-diagnosis of CKD. Kidney Int 89 (2016), 1363–1371.
53. 53 Komenda, P., Rigatto, C., Tangri, N., Screening strategies for unrecognized CKD. Clin J Am Soc Nephrol 11 (2016), 925–927.
54. 54 Ene-Iordache, B., Perico, N., Bikbov, B., et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health 4 (2016), e307–e319.
55. 55 Berns, J.S., Routine screening for CKD should be done in asymptomatic adults… selectively. Clin J Am Soc Nephrol 9 (2014), 1988–1992.
56. 56 Ordunez, P., Saenz, C., Martinez, R., et al. The epidemic of chronic kidney disease in Central America. Lancet Glob Health 2 (2014), e440–e441.
57. 57 Oster, R.T., Virani, S., Strong, D., et al. Diabetes care and health status of First Nations individuals with type 2 diabetes in Alberta. Can Fam Physician 55 (2009), 386–393.
58. 58 Manns, B., Hemmelgarn, B., Tonelli, M., et al. Population based screening for chronic kidney disease: cost effectiveness study. BMJ, 341, 2010, c5869.
59. 59 Siriwardhana, E.A., Perera, P.A., Sivakanesan, R., et al. Is the staple diet eaten in Medawachchiya, Sri Lanka, a predisposing factor in the development of chronic kidney disease of unknown etiology? - A comparison based on urinary beta2-microglobulin measurements. BMC Nephrol, 15, 2014, 103.
60. 60 Boersma, C., Gansevoort, R.T., Pechlivanoglou, P., et al. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands. Clin Ther 32 (2010), 1103–1121.
61. 61 Praveen, D., Patel, A., Raghu, A., et al. SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India. JMIR Mhealth Uhealth, 2, 2014, e54.
62. 62 Whitten, P., Buis, L., Use of telemedicine for haemodialysis: perceptions of patients and health-care providers, and clinical effects. J Telemed Telecare 14 (2008), 75–78.
63. 63 Nakamoto, H., Telemedicine system for patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 27 Suppl 2 (2007), S21–S26.
64. 64 Okpechi, I.G., Swanepoel, C.R., Venter, F., Access to medications and conducting clinical trials in LMICs. Nat Rev Nephrol 11 (2015), 189–194.
65. 65 Swanepoel, C.R., Wearne, N., Okpechi, I.G., Nephrology in Africa–not yet uhuru. Nat Rev Nephrol 9 (2013), 610–622.
66. 66 The ADAPTE Collaboration (2009). The ADAPTE Process: Resource Toolkit for Guideline Adaptation. Version 2.0. Available at: http://www.g-i-n.net.
67. 67 Romanowski, K., Clark, E.G., Levin, A., et al. Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int 90 (2016), 34–40.